Google launches Gemini 3 with new coding app and record benchmark scores — Positive

GOOG  GOOGL   TechCrunch — November 18, 2025

On Tuesday, Google released Gemini 3, its latest and most advanced foundation model, which is now immediately available through the Gemini app and AI search interface.

image for news Google launches Gemini 3 with new coding app and record benchmark scores

OSHKOSH, Wis.--(BUSINESS WIRE)---- $OSK #oshkoshcorporation--Oshkosh Corporation (NYSE: OSK), a leading innovator of purpose-built vehicles, equipment and services, will participate in a fireside chat at the UBS Global Industrials and Transportation Conference. Presenting on behalf of Oshkosh will be President and CEO, John Pfeifer. The event is scheduled to start at 2:40 p.m. EST on December 2, 2025. A live webcast of the presentation can be accessed via the company's website at www.oshkoshcorp.com. A replay of the webcas.

image for news Oshkosh Corporation to Participate in the UBS Global Industrials and Transportation Conference

— Non-Cystic Fibrosis Bronchiectasis (NCFB) Is a Serious, Progressive Lung Disease That Can Lead to Permanent Lung Damage — — BRINSUPRI Is a First-in-Disease, First-in-Class DPP1 Inhibitor Targeting Neutrophilic Inflammation — — BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — BRIDGEWATER, N.J. , Nov. 18, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that the European Commission has approved BRINSUPRI (brensocatib 25 mg tablets) for the treatment …

image for news European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union

SAN FRANCISCO--(BUSINESS WIRE)--Okta, Inc. (NASDAQ:OKTA), the leading independent identity partner, today announced that it has been recognized as a Leader in the 2025 Gartner Magic Quadrant for Access Management for the ninth consecutive year. A complimentary version of the full report can be found here. Gartner defines access management (AM) as tools that include authentication, authorization, single sign-on (SSO), and adaptive access capabilities for modern standards-based web applications,.

image for news Okta Named a Leader in 2025 Gartner® Magic Quadrant™ for Access Management for Ninth Consecutive Year

SANTA ROSA, Calif.--(BUSINESS WIRE)--Compact, modular system with integrated multi-test capability and up to 20-core parallel testing for high-volume efficiency.

image for news Keysight Introduces Scalable, Modular, All-in-One Testing Solution to Accelerate High-Volume PCBA Manufacturing

MILWAUKEE--(BUSINESS WIRE)--Rockwell Automation, Inc. (NYSE:ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced plans to build a new greenfield manufacturing site in Southeastern Wisconsin. The project marks the next step in the company's previously announced $2 billion investment in plants, digital infrastructure, and talent to grow share, build resilience, and expand margins over the next five years. The facility has the potential t.

image for news Rockwell Automation to Build New Greenfield Manufacturing Site in Southeastern Wisconsin

ALX Oncology to Present at Upcoming Investor Conferences — Neutral

ALXO   GlobeNewsWire — November 18, 2025

SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37th Annual Global Healthcare Conference in New York.

image for news ALX Oncology to Present at Upcoming Investor Conferences

SUNNYVALE, Calif.--(BUSINESS WIRE)--Proofpoint, Inc., a leading cybersecurity and compliance company, today announced the general availability of its Proofpoint Satori™ Emerging Threats Intelligence Agent for Microsoft Security Copilot. “AI is the force multiplier for defenders, and when partners bring their agentic innovation into the Security Copilot ecosystem, the impact is exponential. Together, we're not just building tools—we're creating a new era of intelligent, collaborative cyber defen.

image for news Proofpoint Satori™ Emerging Threats Intelligence Agent Now Generally Available for Microsoft Security Copilot

James Hardie Industries plc (JHX) Q2 2026 Earnings Call Transcript — Neutral

JHX   Seeking Alpha — November 18, 2025

James Hardie Industries plc ( JHX ) Q2 2026 Earnings Call November 18, 2025 8:00 AM EST Company Participants Joe Ahlersmeyer - Vice President of Investor Relations Aaron Erter - CEO & Executive Director Jonathan Skelly - President – AZEK Residential Conference Call Participants Trevor Allinson - Wolfe Research, LLC Keith Hughes - Truist Securities, Inc., Research Division Lee Power - JPMorgan Chase & Co, Research Division Ryan Merkel - William Blair & Company L.L.C., Research Division Timothy Wojs - Robert W.

image for news James Hardie Industries plc (JHX) Q2 2026 Earnings Call Transcript

Gladstone Capital (GLAD) Q4 2025 Earnings Call Transcript — Neutral

GLAD   Seeking Alpha — November 18, 2025

Gladstone Capital ( GLAD ) Q4 2025 Earnings Call November 18, 2025 8:30 AM EST Company Participants David Gladstone - Chairman & CEO Catherine Gerkis - Director of Investor Relations & ESG Robert Marcotte - President Nicole Schaltenbrand - CFO & Treasurer Conference Call Participants Erik Zwick - Lucid Capital Markets, LLC, Research Division Christopher Nolan - Ladenburg Thalmann & Co. Inc., Research Division Robert Dodd - Raymond James & Associates, Inc., Research Division Presentation Operator Greetings, and welcome to the Gladstone Capital Corporation Fourth Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

image for news Gladstone Capital (GLAD) Q4 2025 Earnings Call Transcript

Anthropic to buy $30 billion in Azure capacity in new deal with Microsoft, Nvidia — Positive

MSFT  NVDA   CNBC Television — November 18, 2025

Microsoft on Tuesday announced new strategic partnerships with Nvidia and the artificial intelligence startup Anthropic, the latest sign that the company is working to reduce its dependence on OpenAI.

image for news Anthropic to buy $30 billion in Azure capacity in new deal with Microsoft, Nvidia

Home Depot Stock Slides as Weak Demand Dings Earnings — Negative

HD   Schaeffers Research — November 18, 2025

Shares of blue chip Home Depot Inc (NYSE:HD) are off 3.9% to trade at $345.93, after the home improvement chain reported adjusted third-quarter earnings of $3.74 per share, which fell short of estimates.

image for news Home Depot Stock Slides as Weak Demand Dings Earnings

Will U.S. Onshoring and Chip Megaprojects Drive Sterling's Growth? — Positive

STRL   Zacks Investment Research — November 18, 2025

STRL gains momentum as U.S. onshoring and chip megaprojects fuel demand for its mission-critical and expanding E-Infrastructure work.

image for news Will U.S. Onshoring and Chip Megaprojects Drive Sterling's Growth?

Euroseas Ltd. (ESEA) Lags Q3 Earnings and Revenue Estimates — Negative

ESEA   Zacks Investment Research — November 18, 2025

Euroseas Ltd. (ESEA) came out with quarterly earnings of $4.23 per share, missing the Zacks Consensus Estimate of $4.4 per share.

image for news Euroseas Ltd. (ESEA) Lags Q3 Earnings and Revenue Estimates

Wall Street Analysts Believe Masimo (MASI) Could Rally 26.6%: Here's is How to Trade — Positive

MASI   Zacks Investment Research — November 18, 2025

The mean of analysts' price targets for Masimo (MASI) points to a 26.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Believe Masimo (MASI) Could Rally 26.6%: Here's is How to Trade

HireQuest (HQI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now — Positive

HQI   Zacks Investment Research — November 18, 2025

After losing some value lately, a hammer chart pattern has been formed for HireQuest (HQI), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

image for news HireQuest (HQI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Hippo Holdings (HIPO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now — Positive

HIPO   Zacks Investment Research — November 18, 2025

Hippo Holdings (HIPO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

image for news Hippo Holdings (HIPO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

The mean of analysts' price targets for Jade Biosciences, Inc. (JBIO) points to a 52.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 29.1% in Valley National (VLY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Think Valley National (VLY) Could Surge 29.05%: Read This Before Placing a Bet

Tvardi (TVRD) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now — Positive

TVRD   Zacks Investment Research — November 18, 2025

Tvardi (TVRD) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

image for news Tvardi (TVRD) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now